Breastlink Medical Group, Inc.

Orange, California 92868

0 studies enrolling now · 3 studies all time

What they study most

Advanced Breast Cancer, HER2+ Metastatic Breast Cancer (MBC), Metastatic Breast Cancer

Studies at this site

• Palbociclib in Real World Practice — Completed
• Palbociclib (PD-0332991) Combined With Fulvestrant In Hormone Receptor+ HER2-Negative Metastatic Breast Cancer After Endocrine Failure (PALOMA-3) — Completed
• A Study of Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in Patients With HER2+ Metastatic Breast Cancer Who Have Received Two or More Prior HER2 Directed Regimens in the Metastatic Setting — Completed